SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-24-000053
Filing Date
2024-05-17
Accepted
2024-05-17 11:21:36
Documents
14
Period of Report
2024-05-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240517.htm   iXBRL 8-K 32430
  Complete submission text file 0000200406-24-000053.txt   213835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240517.xsd EX-101.SCH 3333
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240517_def.xml EX-101.DEF 16713
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240517_lab.xml EX-101.LAB 30867
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240517_pre.xml EX-101.PRE 17560
17 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240517_htm.xml XML 6219
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 24958325
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)